Tropical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: A randomized, double-blind, placebo-controlled study

British Journal of Clinical Pharmacology

Volumn 49, Issue 6, 2000, Pages 574-579

  McCleane, Gary ^a  

^a CRAIGAVON AREA HOSPITAL   (United Kingdom)

Author keywords

Capsaicin; Doxepin; Neuropathic pain; Tricyclic antidepressants

Indexed keywords

ANALGESIC AGENT; CAPSAICIN; DOXEPIN; TRICYCLIC ANTIDEPRESSANT AGENT; XEPIN; ZACIN;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; MALE; NEUROPATHY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; CHRONIC DISEASE; MIDDLE AGED; PAIN; PAIN ASSESSMENT; PARESTHESIA; PERIPHERAL NEUROPATHY; PSYCHOLOGICAL ASPECT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CAPSAICIN; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DOXEPIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PARESTHESIA; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0033625754     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00200.x     Document Type: Article

References (28)

1. 1 McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Br Med J 1996; 68: 217-227.
2. 2 Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987; 37: 589-596.
3. 3 Watson CP, Evans RJ. A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia. Pain 1985; 23: 387-394.
4. 4 Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988; 38: 1427-1432.
5. 5 Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982; 32: 671-673.
6. 6 Kishore-Kumar R, Max MB, Schafer SC, et al. Desimipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990; 47: 305-312.
7. 7 Max MB, Kishore-Kumar R, Schafer SC, et al. Efficacy of desimipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 1991; 45: 3-9.
8. 8 Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desimipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326: 1250-1256.
9. 9 Sindrup SH, Gram LF, Skjold T, Grodum E, Brosen K, Beck-Nielsen H. Clomipramine vs desimipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol 1990; 30: 683-691.
10. 10 Langohr HD, Stohr M, Petruch F. An open and double-blind cross-over study on the efficacy of clomipramine (Anafranil) in patients with painful mono-and polyneuropathies. Eur Neurol 1982; 21: 309-317.
11. 11 Kvinesdal B, Molin J, Froland A, Gram LF. Imipramine treatment of painful diabetic neuropathy. JAMA 1984; 251: 1727-1730.
12. 12 Lund A, Mjellem-Joly N, Hole K. Chronic administration of desimipramine and zimelidine changes the behaviour response in the formalin test in rats. Neuropharmacology 1991; 30: 481-487.
13. 13 Acton J, McKenna JE, Melzack R. Amitriptyline produces analgesia in the formalin pain test. Exp Neurol 1992; 117: 94-96.
14. 14 Bianchi M, Rossoni G, Sacerdote P, Panerai AE, Berti F. Effects of clomipramine and fluoxetine on subcutaneous carrageenin-induced inflammation in the rat. Inflamm Res 1995; 44: 466-469.
15. 15 Michelson D, Misiewicz-Poltorak B, Raybourne RB, Gold PW, Sternberg EM. Imipramine reduces the local inflammatory response to carrageenin. Agents Actions 1994; 42: 25-28.
16. 16 Sawynok J, Reid AR, Esser MJ. Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine. Pain 1999; 80: 45-55.
17. 17 Turnbull A. Tincture of capsicum as a remedy for chilblains and toothache. Dublin Med Press 1850; 95: 6-7.
18. 18 Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Millikan LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 1989; 21: 265-270.
19. 19 Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Therapeutics 1993; 15: 510-525.
20. 20 Watson CP, Evans RJ, Watt VR. Post-herpetic neuralgia and topical capsaicin. Pain 1988; 33: 333-340.
21. 21 The Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991; 151: 2225-2229.
22. 22 Capsaicin Study Group. Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 1992; 15: 159-165.
23. 23 Ellison N, Loprinzi CL, Kugler J, et al. Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncology 1997; 15: 2974-2980.
24. 24 Rains C, Bryson HM. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Ageing 1995; 7: 317-328.
25. 25 McCleane GJ. Topical doxepin hydrochloride reduces neuropathic pain: a randomised, double-blind, placebo controlled study. The Pain Clinic, 2000; 2: 47-50.
26. 26 Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group Arch Dermatol 1995; 131: 1403-1408.
27. 27 Drake LA, Fallon JD, Sober A. Relief of pruritis in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group. J Am Acad Dermatol 1994; 31: 613-616.
28. 28 Faulkner RD, Pitts WM, Lee CS, Lewis WA, Fann WE. Multiple-dose doxepin kinetics in depressed patients. Clin Pharmacol Ther 1983; 34: 509-515.